Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction. A Randomized Clinical Trial.

NCT03950700 is registered in ClinicalTrials.gov with CES University as lead sponsor.

NCT NCT03950700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03950700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bupivacaine in the Treatment of Postoperative Pain of Impacted Third Molar Extraction. A Randomized Clinical Trial.
Lead sponsor
CES University
Phase
Phase 4
Overall status
Completed
Start date
June 1, 2019
Completion date
January 1, 2020
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

teeth, impacted